Overview
EVH market data
Price History
EVH price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$4.68 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.03 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -24.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.10 – $10.08 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $485M · P/B 1.08 · P/S 0.23.
Company News
Tiger Global Management Increases Stake In Evolent Health Inc By 99% To 11,063,912 SharesBenzinga · Aug 14, 2026, 6:23 PM
Truist Securities Maintains Hold on Evolent Health, Lowers Price Target to $6Benzinga · Aug 12, 2026, 5:26 PM
Citigroup Upgrades Evolent Health to Buy, Lowers Price Target to $6Benzinga · Aug 11, 2026, 12:19 PM
Canaccord Genuity Maintains Buy on Evolent Health, Lowers Price Target to $6Benzinga · Aug 10, 2026, 12:09 PM
Evolent Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates.Benzinga · Aug 6, 2026, 12:40 PM
Evolent Health Raises FY2026 Sales Guidance from $2.400B-$2.600B to $2.600B-$2.700B vs $2.503B EstBenzinga · Aug 6, 2026, 11:06 AM
Evolent Health Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $652.520M Beat $597.997M EstimateBenzinga · Aug 6, 2026, 11:05 AM
8-K filing — Evolent Health, Inc. (EVH)SEC EDGAR · Aug 6, 2026, 11:03 AM
TD Cowen Maintains Buy on Evolent Health, Lowers Price Target to $5Benzinga · Jul 28, 2026, 4:03 PM
Evolent Health shares are trading lower after Citigroup downgraded the stock from Buy to Neutral.Benzinga · Jul 23, 2026, 5:25 PM